![]() |
Today's News |
CloudMD Announces Cost Optimization and Operational Integration Activities, Kandchan Thindal Steps Down as COO
Thursday, April 7, 2022Company Profile | Follow Company
Victoria, BC, April 7, 2022--(T-Net)--CloudMD Software & Services Inc. (TSXV: DOC, OTCQX), a healthcare technology and health services company, provided an update this week on its cost optimization process, integration of its comprehensive health services platform, and revised organizational structure.
CloudMD says its cost optimization team is dedicated to creating shareholder and client value through the integration of people, process, and technology across the entire organization.
Since the start of the year, approximately $7.5 million of annualized run-rate costs have been eliminated from the organization through integration, cost-synergies and streamlining operational functions across the entire business.
The company says that the full benefit of these cost savings is expected to be realized in the second quarter. This exceeds the expected $4 million in cost savings the Company previously disclosed.
"We are pleased with our ability to accelerate the identification and elimination of $7.5 million of run-rate costs which we have already been taken out of the business since the beginning of the year. In addition, we have used this opportunity to re-evaluate the organizational structure and streamline our business operations to prioritize exemplary service for our customers. This will result in our customers realizing increased return on investment and return on employee satisfaction," commented John Plunkett, EVP, Transformation and Strategic Planning at CloudMD.
CloudMD says it has executed on its cost optimization strategy to drive sustainable profitability by:
The Company said in a release that it believes there are additional efficiencies to be realized as it continues its integration efforts this year. In addition, CloudMD says it is also focused on cross-sell revenue synergies through its complete and connected health ecosystem, which will support continued strong top-line growth.
As part of the cost optimization, CloudMD has made some changes to its organizational structure to streamline the operations and create a more efficient business.
Several positions have been reorganized and / or consolidated to leverage important capabilities, share best practices and drive growth throughout the organization.
As part of the reorganization, effective March 31, 2022, Kanchan Thindal has stepped down as the Company's Chief Operating Officer (COO). Karen Adams, President, will assume the roles and responsibilities of COO for the Company.
Through the organizational restructure, CloudMD has made several changes to consolidate and strengthen the depth of its leadership team including appointing Lu Barbuto, EVP Enterprise Health Solutions; Adam Kelly, Chief Commercial Officer; Aida Begovic, EVP Digital Health Solutions; John Plunkett, EVP Transformation and Strategic Planning; Jon Harju, SVP, Engineering; Bronwyn Ott, SVP, Human Resources and Olga McRae, Corporate Secretary.
CloudMD says it has also introduced a process to continually review and evaluate its operational integration and additional changes may be implemented as indicated by such process.
No changes have been made to CloudMD's current business units, Clinics & Pharmacies, Digital Health Solutions and Enterprise Health Solutions.
"Execution of our strategy is dependent on diligent cost management throughout the year. We are focusing on higher productivity and sustainable cost effectiveness to position us for increased profit and scalability," stated Karen Adams, President of CloudMD. "The focus is on delivering the product vision, while ensuring we have the operating model and capabilities to deliver profitable growth. The actions we are announcing today, and the processes we have introduced, will better align our organization and cost structure to achieve these objectives. We will continue driving revenue and margin expansion by adding capabilities to our patented integrated healthcare platform, cross selling our capabilities portfolio, and bringing new, innovative healthcare solutions to the market."
About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient's healthcare journey and provides better access to care and improved outcomes.
Through CloudMD's proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD's business is separated into three main divisions: Clinics and Pharmacies, Digital Solution and Enterprise Health Solutions, the Company's fastest growing division.
CloudMD's Enterprise Health Solutions Division has built a leading employer healthcare solutions, including its Comprehensive Integrated Health Services Platform, which offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.
CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. FORWARD-LOOKING STATEMENTS This press release contains "forward-looking statements" and "forward-looking information" within the meaning of Canadian securities laws. Forward-looking statements in this press release include, but are not limited to, statements with respect to the impact and benefits of the transaction, the mailing of the information circular, anticipated timing for completion of the transaction and receiving the required regulatory, court and shareholder approvals. [ MORE ] |
Other Recent Company News ![]() |
|||||||||||||||||||
|